Effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine on the blood-brain barrier permeability in the rat

European Journal of Pharmacology

Volumn 387, Issue 1, 2000, Pages 63-72

  Deli, Mária A ^a   Németh, László ^b   Falus, András ^c   Ábrahám, Csongor S ^a  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Blood brain barrier; Brain edema; Cerebral ischemia reperfusion; DPPE (N,N diethyl 2 4 (phenylmethyl)phenoxy ethanamine); Histamine; Intracellular histamine binding site

Indexed keywords

ALBUMIN; FLUORESCEIN SODIUM; HISTAMINE; TESMILIFENE;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; MALE; NONHUMAN; PARIETAL LOBE; PERMEABILITY; PRIORITY JOURNAL; RAT; REPERFUSION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CAPILLARY PERMEABILITY; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; EVANS BLUE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FLUORESCEIN; HISTAMINE ANTAGONISTS; INJECTIONS, INTRAVENOUS; MALE; PARIETAL LOBE; PHENYL ETHERS; RATS; RATS, WISTAR; REPERFUSION INJURY; SERUM ALBUMIN;

EID: 0343819905     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00796-7     Document Type: Article

References (63)

1. Ábrahám C.S., Deli M.A., Joó F., Megyeri P., Torpier G. Intracarotid tumor necrosis factor-α administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis. Neurosci. Lett. 208:1996;85-88.
2. Ábrahám C.S., Deli M.A., Temesvári P., Kovács J., Szerdahelyi P., Joó F., Torpier G. Regional differences in asphyxia- and reperfusion-induced cytotoxic and vasogenic brain edema formation in newborn pigs. Neurosci. Res. Commun. 25:1999;. in press.
3. Adachi N., Itoh Y., Oishi R., Saeki K. Direct evidence for increased continuous histamine release in the striatum of conscious freely moving rats produced by middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 12:1992;477-483.
4. Baldwin A.L., Thurston G. Changes in endothelial actin cytoskeleton in venules with time after histamine treatment. Am. J. Physiol. 269:1995;H1528-H1537.
5. Barone F.C., Knudsen D.J., Nelson A.H., Feuerstein G.Z., Willette R.N. Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy. J. Cereb. Blood Flow Metab. 13:1993;683-692.
6. Brandes L.J., Bracken S.P. The intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)-phenoxy]ethanamine·HCl, may potentiate doxorubicin in the treatment of metastatic breast cancer: results of a pilot study. Breast Cancer Res. Treat. 49:1998;61-68.
7. Brandes L.J., LaBella F.S., Glavin G.B., Paraskevas F., Saxena S.P., McNicol A., Gerrard J.M. Histamine as an intracellular messenger. Biochem. Pharmacol. 40:1990;1677-1681.
8. Brandes L.J., LaBella F.S., Warrington R.C. Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists. J. Natl. Cancer Inst. 83:1991;1329-1336.
9. Brandes L.J., Simons K.J., Bracken S.P., Warrington R.C. Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents. J. Clin. Oncol. 12:1994;1281-1290.
10. Brandes L.J., Bracken S.P., Ramsey E.W. N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: an active, low-toxicity regimen for metastatic hormonally unresponsive prostate cancer. J. Clin. Oncol. 13:1995;1398-1403.
11. Brandes L.J., Queen G.M., LaBella F.S. Potent interaction of histamine and polyamines at microsomal cytochrome P450, nuclei, and chromatin from rat hepatocytes. J. Cell. Biochem. 69:1998;233-243.
12. Broadwell R.D., Banks W.A. Cell biological perspective for the transcytosis of peptides and proteins through the mammalian blood-brain fluid barriers. Pardridge W.M. The Blood-Brain Barrier: Cellular and Molecular Biology. 1993;165-199 Raven Press, New York, NY.
13. Butt A.M., Jones H.C. Effect of histamine and antagonists on electrical resistance across the blood-brain barrier in rat brain-surface microvessels. Brain Res. 569:1992;100-105.
14. Cramer W.C.M., Toorop G.P. Focal cerebral ischemia in the mouse: hypothermia and rapid screening of drugs. Gen. Pharmacol. 30:1998;195-205.
15. Deli M.A., Dehouck M.-P., Ábrahám C.S., Cecchelli R., Joó F. Penetration of small molecular weight substances through cultured bovine brain capillary endothelial cell monolayers: the early effects of cyclic adenosine 3′,5′-monophosphate. Exp. Physiol. 80:1995;675-678.
16. Deli M.A., Dehouck M.-P., Cecchelli R., Ábrahám C.S., Joó F. Histamine induces a selective albumin permeation through the blood-brain barrier in vitro. Inflammation Res. 44:1995;S56-S57.
17. Dux E., Joó F. Effects of histamine on brain capillaries. Fine structural and immunohistochemical studies after intra-carotid infusion. Exp. Brain Res. 47:1982;252-258.
18. Dux E., Temesvári P., Szerdahelyi P., Nagy Á., Kovács J., Joó F. Protective effects of antihistamines on cerebral edema induced by experimental pneumothorax in newborn piglets. Neuroscience. 24:1987;317-322.
19. Edvinsson L., MacKenzie E.T., McCulloch J. Histamine. Cerebral Blood Flow and Metabolism. 1993;313-324 Raven Press, New York, NY.
20. Falus A., Merétey K. Histamine: an early messenger in inflammatory and immune reactions. Immunol. Today. 13:1992;154-156.
21. Gross P.M., Teasdale G.M., Angerson W.J., Harper A.M. H2-receptors mediate increases in permeability of the blood-brain barrier during arterial histamine infusion. Brain Res. 210:1981;396-400.
22. Huszti Z., Deli M.A., Joó F. Carrier-mediated uptake and release of histamine by cultured rat cerebral endothelial cells. Neurosci. Lett. 184:1995;185-188.
23. Huszti Z., Madarász E., Schlett K., Joó F., Szabó A., Deli M. Mercury-stimulated histamine uptake and binding in cultured astroglial and cerebral endothelial cells. J. Neurosci. Res. 48:1997;71-81.
24. Hyder S.M., Stancel G.M., Chiapetta C., Murthy L., Boettger-Tong H.L., Makela S. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res. 56:1996;3954-3960.
25. Joó F. The role of histamine in brain oedema formation. Funct. Neurol. 8:1993;243-250.
26. Joó F. Endothelial cells of the brain and other organ systems: some similarities and differences. Prog. Neurobiol. 48:1996;255-273.
27. Joó F., Dux E., Karnushina I.L., Halász N., Gecse Á., Ottlecz A., Mezei Z. Histamine in brain capillaries. Agents Actions. 11:1981;129-134.
28. 2 receptor mRNA levels by dexamethasone in cerebral endothelial cells. J. Cereb. Blood Flow Metab. 19:1999;321-330.
29. Karnushina I.L., Palacios J.M., Barbin G., Dux E., Joó F., Schwartz J.C. Histamine-related enzymes and histamine receptors in isolated brain capillaries. Agents Actions. 9:1979;89-90.
30. Karnushina I.L., Palacios J.M., Barbin G., Dux E., Joó F., Schwartz J.C. Studies on a capillary-rich fraction isolated from brain: histaminic components and characterization of the histamine receptors linked to adenylate cyclase. J. Neurochem. 34:1980;1201-1208.
31. Kis B., Szabó C.A., Pataricza J., Krizbai I.A., Mezei Z., Gecse Á., Telegdy G., Papp J.G., Deli M.A. Vasoactive substances produced by cultured rat brain endothelial cells. Eur. J. Pharmacol. 368:1999;35-42.
32. Koenig H., Goldstone A.D., Lu C.Y. Blood brain barrier breakdown in brain edema following cold injury is mediated by microvascular polyamines. Biochem. Biophys. Res. Commun. 116:1983;1039-1048.
33. Kovács J., Kaszaki J., Temesvári P., Czesznak A., Ábrahám C.S., Joó F. The role of cerebral microvessels in the elimination of histamine released during postasphyxial reperfusion in newborn piglets. Neurosci. Lett. 195:1995;25-28.
34. Mayhan W.G. Role of nitric oxide in histamine-induced increases in permeability of the blood-brain barrier. Brain Res. 743:1996;70-76.
35. Megyeri P., Németh L., Pabst K.M., Pabst M.J., Deli M.A., Ábrahám C.S. 4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor necrosis factor-α-induced blood-brain barrier opening. Eur. J. Pharmacol. 374:1999;207-211.
36. Mohanty S., Dey P.K., Sharma H.S., Singh S., Chansouria J.P.N., Olson Y. Role of histamine in traumatic brain edema. An experimental study in the rat. J. Neurol. Sci. 90:1989;87-97.
37. Németh L., Szabó C.A., Deli M.A., Krizbai I.A., Kovács J., Ábrahám C.S., Joó F. Intracarotid histamine administration results in dose-dependent vasogenic brain oedema formation in new-born pigs. Inflammation Res. 46:1997;S45-S46.
38. Németh L., Deli M.A., Falus A., Szabó C.A., Ábrahám C.S. Cerebral ischemia-reperfusion induced vasogenic brain edema formation in rats: effect of an intracellular histamine receptor antagonist. Eur. J. Pediatr. Surg. 8:1998;216-219.
39. Németh L., Szabó C.A., Deli M.A., Kovács J., Krizbai I.A., Ábrahám C.S. Cerebral microvascular acid phosphatase isoenzymes may contribute to the histamine-induced changes in the blood-brain barrier permeability. Neurosci. Res. Commun. 24:1999;125-133.
40. Norrby K. Evidence of a dual role of endogenous histamine in angiogenesis. Int. J. Exp. Pathol. 76:1995;87-92.
41. O'Neill M., Caldwell M., Earley B., Canney M., O'Halloran A., Kelly J., Leonard B.E., Junien J.L. The sigma receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia. Eur. J. Pharmacol. 283:1995;217-225.
42. Orr E.L. Cryogenic lesions induce a mast cell-dependent increase in cerebral cortical histamine levels in the mouse. Neurochem. Pathol. 8:1988;43-51.
43. Plateel M., Teissier E., Cecchelli R. Hypoxia dramatically increases the nonspecific transport of blood-borne proteins to the brain. J. Neurochem. 68:1997;874-877.
44. Pulsinelli W.A., Brierley J.B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke. 10:1979;267-272.
45. Purkiss J.R., West D., Wilkes L.C., Scott C., Yarrow P., Wilkinson G.F., Boarder M.R. Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histamine, endothelin and purinoceptor agonists. Br. J. Pharmacol. 111:1994;1041-1046.
46. 2+] in cultured rat brain capillary endothelial cells. Brain Res. 549:1991;159-161.
47. Riberio J.M.C., Walker F.A. High affinity histamine-binding and antihistaminic activity of the salivary nitric oxide-carrying heme protein (nitrophorin) of Rhodnius prolixus. J. Exp. Med. 180:1994;2251-2257.
48. Robinson-White A., Beaven M.A. Presence of histamine and histamine-metabolizing enzyme in rat and guinea-pig microvascular endothelial cells. J. Pharmacol. Exp. Ther. 223:1982;440-445.
49. Rotrosen D., Gallin J.I. Histamine type I receptor occupancy increases endothelial cytosolic calcium, reduces F-actin, and promotes albumin diffusion across cultured endothelial monolayers. J. Cell Biol. 103:1986;2379-2387.
50. Scherkl R., Hashem A., Frey H.H. Histamine in brain - its role in regulation of seizure susceptibility. Epilepsy Res. 10:1991;111-118.
51. Schilling L., Wahl M. Opening of the blood-brain barrier during cortical superfusion with histamine. Brain Res. 653:1994;289-296.
52. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., Ruat M. Histaminergic transmission in the mammalian brain. Physiol. Rev. 71:1991;1-51.
53. Sharonova I.N., Vorobjev V.S., Skrebitsky V., Haas H.L. Histamine and NMDA-receptors in the hippocampus: polyamines and intracellular binding site. Inflammation Res. 45:1996;S58-S59.
54. Sturman G., Freeman P., Meade H.M., Seeley N.A. Modulation of the intracellular and H3-histamine receptors and chemically-induced seizures in mice. Agents Actions. 41:1994;C68-C69.
55. Thompson S.E., Cavitt J., Audus K.L. Leucine enkephalin effects on paracellular and transcellular permeation pathways across brain microvessel endothelial cell monolayers. J. Cardiovasc. Pharmacol. 24:1994;818-825.
56. Todd N.V., Picozzi P., Crockard H.A., Ross Russell R.W. Recirculation after cerebral ischaemia. Simultaneous measurement of cerebral bloodflow, brain edema, cerebrovascular permeability and cortical EEG in the rat. Acta Neurol. Scand. 74:1986;269-278.
57. Tomida S., Nowak T.S. Jr., Vass K., Lohr J.M., Klatzo I. Experimental model for repetitive ischemic attacks in the gerbil: the cumulative effect of repeated ischemic insults. J. Cereb. Blood Flow Metab. 7:1987;773-782.
58. Tósaki Á., Szerdahelyi P., Joó F. Treatment with ranitidine of ischemic brain edema. Eur. J. Pharmacol. 264:1994;455-458.
59. Van Buskirk R., McGaugh J.L. Retrograde amnesia and brain seizure activity in mice: strain differences. Exp. Neurol. 51:1976;150-159.
60. Wahl M., Unterberg A., Baethmann A., Schilling L. Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J. Cereb. Blood Flow Metab. 8:1988;621-634.
61. Wang M., Merrill M.J., Borchardt R.T. Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro. Am. J. Physiol. 271:1996;C1973-C1980.
62. Yong T., Bebo B.F., Sapatino B.V., Welsh C.J., Orr E.L., Linthicum D.S. Histamine-induced microvascular leakage in pial venules: differences between the SJL/J and BALB/c inbred strains of mice. J. Neurotrauma. 11:1994;161-171.
63. Yuan Y., Granger H.J., Zawieja D.C., DeFily D.V., Chilian W.M. Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am. J. Physiol. 264:1993;H1734-H1739.